Intercept Pharmaceuticals

Patent cliffs & loss of exclusivity

Intercept Pharmaceuticals is an American biopharmaceutical company

Company

AngelList URLhttps://angel.co/intercept-pharmaceuticals
Legal NameIntercept Pharmaceuticals, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/intercept-pharmaceuticals
Facebook URLhttps://www.facebook.com/pages/Intercept-Pharmaceuticals/621499614608633
Full AddressPaseo de la Castellana 135, 7º piso 28046 Madrid, Spain
Legal Entity Identifier254900JMB8TX5P688V24
LinkedIn URLhttp://www.linkedin.com/company/intercept-pharmaceuticals/

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. LYNAVOYLINERIXIBATSmall mol.Mar 2033
  2. OCALIVAOBETICHOLIC ACIDSmall mol.Apr 2036
  3. OCALIVAOBETICHOLIC ACIDSmall mol.Apr 2036

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.